According to a recent study by UC Irvine researchers.

Study is an important study is an important step in this direction. ‘.. Provides safety to the spinal cord stem cell transplanttransplanting human embryonic stem cells does not harm and can be used as a therapeutic strategy for the treatment of acute spinal cord injury, according to a recent study by UC Irvine researchers. Found UCI neurobiologist Hans Keirstead and colleagues at the Reeve – Irvine Research Center, that rats with either mild or severe spinal cord injuries transplanted transplanted with a treatment of human embryonic stem cells suffered no visible injuries or adverse effects episode – of the treatment itself, the study also confirmed previous findings by Keirstead lab – since replicated by four other laboratories around the world – that replacing a cell type lost after injury improves the outcome after spinal cord injury in rodents.

About the University of California, IrvineThe University of California, Irvine is a top-ranked university dedicated to research, scholarship and community service. Established in 1965, UCI is. Among the fastest-growing University of California, with more than 24,000 undergraduate and graduate students and about 1,400 faculty members The second largest employer in dynamic Orange County carries UCI an annual economic impact of $ 3.3 billion.The clinical trial as one of conferencing was be accepted presentations out of Tianjin Medical University Cancer Institute and Hospital, Tianjin, the study revealed that ‘when CTLM system of as a an adjunct to mammography in heterogeneous and extremely dense breasts, sensitivity was used in increased significantly. ‘Refer to corporate Web site for details to the reported clinical report.

For further information, forward-looking statementsHow the provisions of the provisions of the Safe Harbor part the Securities Litigation Reform Act 1995, in this news release may constitute forward -looking statements with respect to future, anticipated contain, or projection Plan, trendsetting products and developments, as well other statements in terms to future operations. All such forward-looking statements is necessarily only estimates and forecasts regarding future results or events to, and there can not be guaranteed that the actual results or events are not materially differ materially from expectations.